{
    "clinical_study": {
        "@rank": "132919", 
        "acronym": "MISP", 
        "arm_group": [
            {
                "arm_group_label": "Insomnia group", 
                "description": "Assessment of physiologic hyper-arousal across the two following domains:\nNeurophysiologic arousal:  recording of multiple sleep latency test (MSLT), recording of wake electroencephalography (EEG), and quantitative sleep EEG recording and analysis.\nSympathetic neural activity:  recording at the level of the muscle by microneurography and at the level of the heart by spectral analysis of heart rate variability from the ECG signal obtained during sleep and wakefulness."
            }, 
            {
                "arm_group_label": "Matched Control Group", 
                "description": "Assessment of physiologic hyper-arousal across the two following domains:\nNeurophysiologic arousal: recording of multiple sleep latency test (MSLT), recording of wake electroencephalography (EEG), and quantitative sleep EEG recording and analysis.\nSympathetic neural activity: recording at the level of the muscle by microneurography and at the level of the heart by spectral analysis of heart rate variability from the ECG signal obtained during sleep and wakefulness."
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to determine whether individuals with insomnia have a higher\n      degree of physiologic arousal (resulting in their trouble sleeping) than good sleepers.\n      Physiologic arousal will be measured by analyzing the brain waves during wake and during\n      sleep, the heart rate during wake and during sleep and activity in a nerve of the leg."
        }, 
        "brief_title": "Hyper-Arousal in Chronic Primary Insomnia", 
        "completion_date": {
            "#text": "July 2016", 
            "@type": "Anticipated"
        }, 
        "condition": "Insomnia", 
        "condition_browse": {
            "mesh_term": "Sleep Initiation and Maintenance Disorders"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\u2022 Men and women with primary insomnia of at least 3 months in duration\n\n          -  ages 21-65 years old\n\n          -  Body Mass Index (BMI) <30 kg/m2 to enable microneurography\n\n          -  Moderate to severe insomnia based on the Insomnia Severity Index (ISI)\n             questionnaire34\n\n          -  Pittsburgh Sleep Quality Index35 (PSQI) > 5\n\n          -  Sleep efficiency on overnight screening of brain waves (PSG) during sleep recording\n             with total recording time (TRT) of 8 hours <80%\n\n          -  Self-reported habitual sleep duration < 6.5 hours\n\n        Exclusion Criteria:\n\n          -  Sleep disorders other than insomnia as assessed by screening PSG (apnea-hypopnea\n             index or apnea-hypopnea index (AHI) \u2265 5, periodic leg movement (PLM) arousal index \u2265\n             5)\n\n          -  Circadian rhythm sleep disorders\n\n          -  Diabetic based on HbA1c \u2265 6.5 %. For those with HbA1c \u2265 6.0 but <6.5%, the\n             non-diabetic condition will be confirmed by 2-h oral glucose tolerance test\n\n          -  History of meeting diagnostic criteria for any major psychiatric disorder, including\n             mania or alcohol or substance abuse\n\n          -  A Center for Epidemiologic Studies Depression Scale (CES-D) questionnaire score of 16\n             or greater, indicating clinically significant depression36\n\n          -  Unstable or serious medical conditions\n\n          -  Current, or use within the past month, of psychoactive, hypnotic, stimulant or\n             analgesic medications (except occasional non-narcotic analgesics), beta blockers or\n             alpha blockers\n\n          -  Shift work or other types of self imposed irregular sleep schedules\n\n          -  A history of habitual smoking (6 or more cigarettes per week) or caffeine consumption\n             of greater than 300 mg per day\n\n          -  More than 2 alcoholic drinks per day\n\n          -  Pregnancy"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "65 Years", 
            "minimum_age": "21 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Insomniacs"
            }
        }, 
        "enrollment": {
            "#text": "32", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 27, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02048878", 
            "org_study_id": "13-1214"
        }, 
        "is_fda_regulated": "No", 
        "keyword": "Insomnia", 
        "lastchanged_date": "January 28, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Chicago", 
                    "country": "United States", 
                    "state": "Illinois", 
                    "zip": "60637"
                }, 
                "name": "The University of Chicago"
            }, 
            "investigator": [
                {
                    "last_name": "Babak Mokhlesi, MD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Lisa Medalie, MS", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Grimaldi Daniela, MD, PhD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "David Ehrmann, MD", 
                    "role": "Sub-Investigator"
                }
            ], 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_groups": "2", 
        "official_title": "Multi-Level Assessment of Physiologic Hyper-Arousal in Chronic Primary Insomnia: A Case Control Study", 
        "other_outcome": {
            "description": "Direct recording of sympathetic nervous activity in a nerve of the lower leg using a micro-electrode.", 
            "measure": "sympathetic neural activity in a peripheral nerve", 
            "safety_issue": "No", 
            "time_frame": "within 2 months after enrollment"
        }, 
        "overall_contact": {
            "email": "smsallek@medicine.bsd.uchicago.edu", 
            "last_name": "Soumia Smallek", 
            "phone": "773 702 0169"
        }, 
        "overall_official": {
            "affiliation": "University of Chicago", 
            "last_name": "Eve Van Cauter, PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "July 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "The balance between sympathetic and parasympathetic nervous control of the heart will be determined by spectral analysis of heart rate variability using continuous electrocardiogram (ECG) recording for 24 hours, including the normal sleep period.", 
            "measure": "heart rate variability during wake and during sleep", 
            "safety_issue": "No", 
            "time_frame": "within 2 months of enrollment"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02048878"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "The EEG will be measured continuously during sleep and at frequent intervals during wake.  The signal will be submitted to power spectral analysis to examine spectral power in frequency bands that are typical of arousal and in frequency bands that are typical of deep sleep.", 
            "measure": "Electroencephalography (EEG) during wake and sleep", 
            "safety_issue": "No", 
            "time_frame": "within 2 months of enrollment"
        }, 
        "source": "University of Chicago", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University of Chicago", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2014", 
        "study_design": "Observational Model: Case Control, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "January 2014"
    }
}